Further study of deoxyspergualin prophylaxis in living related renal transplantation.
Okazaki
H
H
Department of Surgery, Sendai Shakaihoken Hospital, Japan.
Sato
T
T
Amada
N
N
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005190:Family; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D014019:Tissue Donors
D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D016572:Cyclosporine; D001379:Azathioprine; C037258:gusperimus; D011241:Prednisone